Accession Number:

AD1087102

Title:

Clinical Trial of a Comprehensive Treatment for High-Functioning Children with ASD

Descriptive Note:

Technical Report,01 Jul 2018,30 Jun 2019

Corporate Author:

CANISIUS COLL BUFFALO United States

Personal Author(s):

Report Date:

2019-07-01

Pagination or Media Count:

40.0

Abstract:

The purpose of this RCT is to test the efficacy of an outpatient psychosocial treatment MAXout on the ASD symptoms and social-communicative functioning of 7-12 year olds with HFASD. The treatment targets socialsocial-communication skills, nonliteral language skills, emotion-decoding skills, and interest expansion. Treatment is delivered over 18 weeks two 90 min. sessionswk. with each treatment group consisting of 4 children with HFASD and 2 staff clinicians. Efficacy is assessed immediately following the 18-week treatment and 4-6 weeks post-treatment. Following year 4, significant progress has been made in regard to Major Task 1 RCT objectives which included completion of the following 1 closure of IRB protocol and completion of the regulatory review 2 implementation of the treatment for sampling wave 6 3 completion of pretest, posttest, and follow-up measures for sampling wave 6 4 recruitment and training of staff clinicians and research assistantsfor waitlist controls sampling wave 6 and 5 implementation of the treatment for waitlist controls sampling wave 6. Progress has also been made for Major Task 2 Data Analysis however the time consuming nature of the coding of the videotaped social interactions hindered completion of the 3 subtasks subtask 1 - data compilationquality check subtask 2 - data analyses and subtask 3 - dissemination all are underway and ongoing. These will be completed during the approved Extension without Funds period.

Subject Categories:

  • Medicine and Medical Research
  • Psychology

Distribution Statement:

APPROVED FOR PUBLIC RELEASE